Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22562021 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Reduce Risk for Crohn's Disease Patients
Condition: Crohn's Disease
Interventions: Drug: Methotrexate;   Drug: Adalimumab;   Drug: Azathioprine / 6 Mercaptopurine
2 Completed
Has Results
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Biological: Adalimumab

Indicates status has not been verified in more than two years